A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples